Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazi n1-yl)-1H-benzimidazol-2-yl]-1H-quinolin2-one lactic acid salts

Details for Australian Patent Application No. 2006249847 (hide)

Owner Novartis AG

Inventors Okhamafe, Augustus; Zhu, Shuguang; Harwood, Eric; Ryckman, David; Chou, Joyce; Gullapalli, Rampurna; Shang, Xiao

Agent Davies Collison Cave

Pub. Number AU-A-2006249847

PCT Pub. Number WO2006/127926

Priority 60/683,999 23.05.05 US

Filing date 23 May 2006

Wipo publication date 30 November 2006

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/127926 Priority application(s): WO2006/127926

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249851-Nk-B inhibitors for the treatment of muscular dystrophy

2006249846-Detacher for a security device